Perceptive Advisors’s Anthera Pharmaceuticals ANTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ANTH
Perceptive Advisors's ANTH Position: Q4 2016 in Review
Perceptive Advisors sold out of Anthera Pharmaceuticals (ANTH) in Q4 2016, closing a stake of 182,453 shares — an estimated $4.6M sold.
Perceptive Advisors first reported a position in ANTH in Q2 2013 and held it in 14 quarters. The position peaked at $10.4M in Q2 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q4 2016.
- Perceptive Advisors reported no remaining Anthera Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
- Perceptive Advisors sold 182,453 Anthera Pharmaceuticals shares in Q4 2016, an estimated $4.6M.
- Perceptive Advisors first reported a position in Anthera Pharmaceuticals in Q2 2013 and held it in 14 quarters.
- Perceptive Advisors's Anthera Pharmaceuticals position peaked at $10.4M in Q2 2015.
- 72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals as of Q4 2016.
Based on Perceptive Advisors's 13F filing for Q4 2016, filed 14 Feb 2017.